--- title: "Kestra Medical Technologies: A New Contender in Wearable Defibrillation" description: "Kestra Medical Technologies: A New Contender in Wearable Defibrillation" --- [Skip to content](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation#main-content) [![IPO_PROPHET_BLUE logo](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_BLUE%20logo.png?width=2973&height=302&name=IPO_PROPHET_BLUE%20logo.png)](https://www.IPOProphet.com) - [Login](https://app.ipoprophet.com/login) Open main navigation Close main navigation - [Login](https://app.ipoprophet.com/login) [Subscribe to our Newsletter](https://share.hsforms.com/1xXldKrGiQBCbNmtOz6j4Jwq3cu4) [Go Back to Home](http://www.ipoprophet.com/) [Go Back to Blog](http://www.ipoprophet.com/blog) Feb 27, 2025 12:57:42 PM # Kestra Medical Technologies: A New Contender in Wearable Defibrillation ![Picture of Eric Friedman](https://app.hubspot.com/settings/avatar/7a4cca62b5a89282b41a283a43efa80e) [Eric Friedman](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman) Share: [facebook-f icon](http://www.facebook.com/share.php?u=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation) [linkedin-in icon](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation) [Twitter icon](https://twitter.com/intent/tweet?url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation) [pinterest-p icon](http://pinterest.com/pin/create/link/?url=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation) [envelope icon](mailto:?body=https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation) ![](https://blog.ipoprophet.com/hs-fs/hubfs/image-png-Feb-27-2025-05-33-49-1194-PM.png?width=347&height=166&name=image-png-Feb-27-2025-05-33-49-1194-PM.png) Kestra Medical Technologies, a rising player in the medical device space, is making waves with its upcoming IPO on the Nasdaq under the ticker symbol KMTS. The company, specializing in wearable cardioverter defibrillators (WCDs), is offering 10 million shares at a price range of $14 to $16 per share, positioning itself at a post-offer enterprise value of approximately $715 million. With the backing of lead underwriters such as BofA Securities, Goldman Sachs, and Piper Sandler, Kestra is poised to challenge the market dominance of existing cardiac monitoring solutions. What sets Kestra apart is its **ASSURE WCD**, a next-generation device designed for superior comfort and reduced false alarms, key factors that have historically hindered patient compliance in this field. The proceeds from the IPO, estimated between $133.3 million and $154.2 million, will be strategically allocated to scaling commercial operations, enhancing research and development, and reinforcing the company’s working capital. As Kestra expands its hospital network, with over 550 U.S. hospitals already prescribing its products, the company aims to further penetrate the market by leveraging AI-driven patient monitoring and digital health integration. With a growing focus on telehealth and remote monitoring, Kestra’s **Cardiac Recovery System platform** stands out as a comprehensive solution that combines therapeutic intervention with real-time digital insights, providing both patients and healthcare providers with a more seamless experience. While Kestra’s approach and growth trajectory highlight its potential within the medical device industry, some challenges and risks remain. For example, the company is currently a single-product entity, making it heavily reliant on the success of the ASSURE WCD. Additionally, as a "controlled company" under Bain Capital’s majority ownership, governance concerns may arise. With a total addressable market exceeding $10 billion in the U.S. alone and potential expansion into international markets, Kestra aims to establish itself within the cardiac care industry as it continues to develop its presence and offerings. And with over 17,000 patients wearing the device already, Kestra appears to have given itself a healthy jump start.   [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos), [Kestra Medical Technologies](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/kestra-medical-technologies) ## Related posts [![](https://blog.ipoprophet.com/hs-fs/hubfs/image-png-1.png?height=200&name=image-png-1.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/cava-how-much-is-your-mediterranean-worth-the-shares-not-the-salad) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos) ## [CAVA: How much is your Mediterranean Worth…the shares not the salad](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/cava-how-much-is-your-mediterranean-worth-the-shares-not-the-salad) ![Picture of Scott Shelton](https://app.hubspot.com/settings/avatar/9f39d5740e08012b666d53c25ba6bbc8) [Scott Shelton](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/scott-shelton) Sep 6, 2024 12:53:53 AM As institutional investors specializing in IPO investing, our team at IPO Prophet have observed how... [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/cava-how-much-is-your-mediterranean-worth-the-shares-not-the-salad) [![](https://blog.ipoprophet.com/hs-fs/hubfs/image-png-2.png?height=200&name=image-png-2.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/risk-happens-fast) ## [Risk Happens Fast](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/risk-happens-fast) ![Picture of Scott Shelton](https://app.hubspot.com/settings/avatar/9f39d5740e08012b666d53c25ba6bbc8) [Scott Shelton](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/scott-shelton) Sep 13, 2024 3:26:19 PM "Risk happens fast." This is a phrase I learned in trading and investing quite some time ago, and... [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/risk-happens-fast) [![](https://blog.ipoprophet.com/hs-fs/hubfs/image-png-4.png?height=200&name=image-png-4.png)](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/ipo-prophet-sees-a-new-ipo-cycle-analyzing-issuance-from-2012-2024) [IPOs](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/tag/ipos) ## [IPO Prophet Sees a New IPO Cycle: Analyzing Issuance from 2012 - 2024](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/ipo-prophet-sees-a-new-ipo-cycle-analyzing-issuance-from-2012-2024) ![Picture of Scott Shelton](https://app.hubspot.com/settings/avatar/9f39d5740e08012b666d53c25ba6bbc8) [Scott Shelton](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/scott-shelton) Sep 13, 2024 3:47:36 PM (originally published July 29, 2024) After two very difficult years in the market for issuing... [Read more](https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/ipo-prophet-sees-a-new-ipo-cycle-analyzing-issuance-from-2012-2024) [linkedin-in icon](https://www.linkedin.com/company/ipo-prophet-software/) [X Twitter icon](https://www.x.com/ipoprophet) --- [![IPO_PROPHET_WHITE-2](https://blog.ipoprophet.com/hs-fs/hubfs/IPO_PROPHET_WHITE-2.png?width=800&height=250&name=IPO_PROPHET_WHITE-2.png "IPO_PROPHET_WHITE-2")](http://www.ipoprophet.com) NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE. Copyright © 2025 ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Eric Friedman", "url" : "https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/author/eric-friedman" }, "dateModified" : "2025-02-27T17:57:42.709Z", "datePublished" : "2025-02-27T17:57:42.000Z", "headline" : "Kestra Medical Technologies: A New Contender in Wearable Defibrillation", "mainEntityOfPage" : { "@id" : "https://blog.ipoprophet.com/aslgkuh89gyaep98byanp9t8yaqtp98hyq358yna8pq48y/kestra-medical-technologies-a-new-contender-in-wearable-defibrillation", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.ipoprophet.com/hubfs/IPO_PROPHET_BLUE%20logo-1.png" }, "name" : "ipoprophet.com" } } ```